Hostname: page-component-68c7f8b79f-zmclx Total loading time: 0 Render date: 2026-01-18T03:38:56.197Z Has data issue: false hasContentIssue false
  • English
  • Français

Multimodality treatment in stage IV squamous cell carcinoma of the head and neck. A long-term follow-up

Published online by Cambridge University Press:  29 June 2007

A. Klima ,
I. Bergmann  and
S. Szepesi
A. Klima*
Affiliation:
Frankfurt, Germany
I. Bergmann
Affiliation:
Frankfurt, Germany
S. Szepesi
Affiliation:
Frankfurt, Germany
*
Dr A. Klima, HNO-Universitätsklinik Frankfurt, Th.Stern Kai 7, 6000 Frankfurt/Main, Germany.
Get access Rights & Permissions [Opens in a new window]

Abstract

We treated 114 patients with advanced inoperable head and neck cancer with a combined-modality protocol that included two cycles of chemotherapy followed by radiotherapy or three cycles of chemotherapy and in 18 patients with a radiosensitizing agent. At the beginning of the treatment all but one patient presented with a stage IV cancer. With a follow-up of 42–58 months, four patients are alive (three from the radiosensitizing group and one of the chemotherapy group). Complete response after the radiosensitizing agent correlated with superior prolonged disease-free survival in comparison to complete responses after chemotherapy at the level of p<0.009.

Keywords

Head and neck neoplasmsDrug therapy, combinationRadiotherapy

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 106 , Issue 3 , March 1992 , pp. 234 - 237
Copyright
Copyright © JLO (1984) Limited 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Al-Kourainy, K., Kish, J., Ensley, J., Tapazouglu, E., Jacobs, J., Weaver, A., Crissmann, J. (1987) Achievement of superior survival for histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer, 59: 233–238.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Al-Sarraf, M., Pajak, T. R, Marcial, V. A., Mowry, P., Cooper, J. S., Stetz, J., Ensley, J. F. (1987) Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. Cancer, 59: 259–265.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Amrein, P. C, Fingert, H., Weitzmann, S. A. (1983) Cisplatin-vincristine-bleomycin therapy in sqaumous cell carcinoma of the head and neck. Journal of Clinical Oncology, 1: 421–427.CrossRefGoogle Scholar
Amrein, P. C, Weitzmann, S. A. (1985) Treatment of squamous cell carcinoma of the head and neck with cisplatin and 5-fluorouracil. Journal of Clinical Oncology, 3: 1632–2639.CrossRefGoogle ScholarPubMed
Ensley, J. F., Jacobs, J. R., Weaver, A., Kinzie, J., Crissman, J., Kish, J. A., Cummings, G., Al-Sarraf, M. (1984) Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced sqaumous cell cancers of the head and neck. Cancer, 54: 811–814.3.0.CO;2-E>CrossRefGoogle Scholar
Hong, W. K. (1984) Preoperative adjuvant induction chemotherapy in head and neck cancer. In: Head and Neck Oncology. (Wolf, Martinus T., ed). Nijhoff Publishers, Boston, p. 287–290.CrossRefGoogle Scholar
Jacobs, C., Pajak, T. E, Kinzie, J., Al- Sarraf, M., Davis, L., Hanks, G. A., Weigensbewrg, I., Leibel, S. (1987) Induction chemotherapy in advanced head and neck cancer. Archives of Otolaryngology, 113: 193–197.CrossRefGoogle ScholarPubMed
Kaplan, E. L., Meier, P. (1958) Nonparametric estimation from incomplete observation. American Statistical Association Journal, 53: 457–481.CrossRefGoogle Scholar
Kies, M. S., Gordon, L. I., Hauck, W. W., Krespy, Y., Ossoff, R. H., Pecaro, B., Yuska, C., Lamut, C. H., Brand, W., Chang, S. (1985) Analysis of complete responders after initial treatment with chemotherapy in the head and neck cancer. Otolaryngology—Head and Neck Surgery, 93: 199–205.CrossRefGoogle ScholarPubMed
Kish, J., Ensely, J., Weaver, A., Jacobs, J., Cummings, G., Al-Sarraf, M. (1984) Improvement of complete response rate to induction adjuvant chemotherapy for advanced squamous carcinoma of the head and neck. Adjuvant Therapy of Cancer, iv: 107–115.Google Scholar
Klima, A., Klippstein, T. H., Bergmann, L., Szepesi, S. V., Ilberg, C. (1988) Adjuvant chemotherapy in stage IJJ and IV squamous cell carcinoma of the head and neck. Journal of Laryngology and Otology, 102: 337–340.CrossRefGoogle Scholar
Leipzig, B., Wetmore, S. J., Putzeys, R., Suen, J. Y., Snyderman, N. L. (1985) Cisplatin potentiation of radiotherapy. Long-term follow-up. Archives of Otolaryngology, 111: 114–118.CrossRefGoogle ScholarPubMed
Looser, K. G., Shah, J. P., Strong, E. W. (1978) The significance of ‘positive’ margins in surgically resected epidermoid carcinomas. Head and Neck Surgery, 1: 107–111.CrossRefGoogle ScholarPubMed
Mantravadi, R. V, Haas, R. E., Strong, E. J., Skolnik, E. M., Applebaum, E. L. (1983) Postoperative radiotherapy for persistant tumour at the surgical margin in head and neck cancers. Laryngoscope, 93: 1337–1340.CrossRefGoogle ScholarPubMed
Richmond, R. C., Powers, E. L. (1976) Radiation sensitization of bacterial spores by cis-dichlorodiammine-platinum (II). Radiation Research, 68: 251–257.CrossRefGoogle Scholar
Rooney, M., Kish, J., Jacobs, J., Kinzie, J., Weaver, A., Crissmann, J., Al- Sarraf, M. (1985) Improved complete response rate and survival in advanced head and neck cancer after three course induction therapy with 120h 5-FU infusion and cis-platin. Cancer, 55: 1123–1128.3.0.CO;2-8>CrossRefGoogle Scholar
Snydermann, N. L., Wetmore, S. J., Suen, J. Y. (1986) Cisplatin sensitization to radiotherapy in stage IV squamous cell carcinoma of the head and neck. Archives of Otolaryngology, 112: 1147–1150.CrossRefGoogle Scholar
Spaulding, M. B., Lore, J. M., Sundquist, R. N. (1989) Long-term follow-up of chemotherapy in advanced head and neck cancer. Archives of Otolaryngology, Head and Neck Surgery, 115: 68–73.CrossRefGoogle ScholarPubMed
Toohill, R. J., Duncavage, J. A., Grossman, T. W., Malin, Teplin, R. W., Wilson, J. E., Byhardt, R. W, Haas, J. S., Cox, J. D., Anderson, T. (1987) The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies. Laryngoscope, 97: 407–412.CrossRefGoogle ScholarPubMed
U.I.C.C. (1987) Union internationale contre le cancer. T.N.M. General Rules. Third edition, Genf.Google Scholar
Wang, K. H., Bromer, R. (1983) Chemotherapy in head and neck cancer. New England Journal of Medicine, 308: 75–83.Google Scholar
WHO (1976) International Classification of Diseases for Oncology. Geneva, 1976.Google Scholar
Wodinsky, I., Swiniarski, J., Kensler, C. J., Venditti, J. M. (1974) Combination radiotherapy and chemotherapy for P388 lymphocytic leukemia in vitro. Cancer Treatment Report, 4: 73–78.Google Scholar